BioSpace News Archive

Genetown

Enveric Biosciences Celebrates and Supports 2023 Mental Health Awareness Month

Enveric Biosciences, Inc. today announced its support of Mental Health Awareness Month this May as the company advances its novel development programs to improve the treatment of mental health disorders.

May 2, 2023
·
6 min read
BioMidwest

Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors

Hygieia is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.

May 2, 2023
·
3 min read
Lone Star Bio

Lantern Pharma Develops Top-Ranked AI Algorithms to Predict the Blood-Brain-Barrier Permeability of Any Compound

Lantern Pharma Inc. today announced that it has developed highly-accurate and industry-leading AI algorithms to predict the ability of a drug or compound to pass the blood-brain-barrier (BBB), a highly selective border that can prevent drugs from entering brain tissues.

May 2, 2023
·
7 min read
Business

Savaria Announces Date for First Quarter 2023 Financial Results

Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the accessibility industry, announces it will release its financial results for the first quarter of 2023 after market close on May 10, 2023.

May 2, 2023
·
1 min read
FDA

Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201

Tenaya Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its gene therapy product candidate, TN-201, being developed for the treatment of Myosin Binding Protein C3 (MYBPC3)-associated hypertrophic cardiomyopathy (HCM).

May 2, 2023
·
7 min read
Business

Viridian Therapeutics to Webcast First Quarter 2023 Financial Results and Corporate Update on May 9, 2023

Viridian Therapeutics, Inc. (NASDAQ: VRDN) today announced it will host a webcast and conference call on Tuesday, May 9, 2023 at 4:30 p.m. ET to discuss its first quarter 2023 financial results and provide a corporate update.

May 2, 2023
·
1 min read
Bio NC

Science 37 Joins Partnership in Support of White House CancerX and Cancer Moonshot

Science 37 Holdings, Inc., the industry-leading MetasiteTM, announced its partnership with the Digital Medicine Society in support of the CancerX inaugural project.

May 2, 2023
·
5 min read
Business

Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023

Mersana Therapeutics, Inc. (NASDAQ: MRSN) today announced that it will provide business updates and report its financial results for the first quarter ended March 31, 2023 on Tuesday, May 9, 2023.

May 2, 2023
·
1 min read
Genetown

CRISPR Therapeutics to Participate Upcoming May 2023 Investor Conferences

CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced that members of its senior management team are scheduled to participate in fireside chats at the following investor conferences in May.

May 2, 2023
·
1 min read
Pharm Country

Intra-Cellular Therapies to Present at Two Upcoming May 2023 Investor Conferences

Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, announced that it will present at two upcoming investor conferences.

May 2, 2023
·
1 min read